|From: trendtn (Rep: 161)||Date: 02/13/2018 10:44|
|Forum: Cellectis SA - Msg #107||Thread #673990944 (Rec: 0) |
|Clls...now a crispr stock|
Cellectis was granted an ancillary crispr patent. I previously saw this as a car-t play...they are developing an off the shelf universal...the medical term is allogenic ....cancer immuno therapy.
With today's news they become a full fledged crispr stock. I own some from the fall to 23s on a FDA halt a couple months back that was subsequently lifted...they almost always are btw. I added today on the crispr news
For those keeping track the crispr stocks are edit...ntla. ..crsp and now clls.
I own them all because I believe it's inevitable that crispr will become a stock theme of staggering significance. All of these are investments. .not trades. I suggest you own a little of any or all of them and just forget about it...your kids,will thank you.
Btw blcm is in an FDA halt that I think will be lifted...it's a car-t...it's bought the fall mid 5s and expect it to recover when the halt is liftrd
TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.